Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags:
The Obama administration estimates it will cost about $120 billion to cover roughly 50 million uninsured. Everything from taxing high calorie sodas, limiting tax dedcuctions for charitable giving, or decuctions for employer provided health insurance, are all being looked at Some like limiting deductions on chartable giving lack support in Congress.
Grouped Articles
Health Battle Over Soda Flares in Mexico
Wall Street Journal 08/28/2013
Recession Swells Number of Uninsured to 50.7 Million
Wall Street Journal 09/17/2010
Exchanges See Little Progress on Uninsured
Wall Street Journal 01/20/2014
Wal-Mart Cuts Prices for Many Generic Drugs to $4 - WSJ.com
Wall Street Journal 09/22/2006
A J&J Copycat Could Extend Old Drug's Life - WSJ.com
Wall Street Journal 09/29/2006
As Patients, Doctors Feel Pinch, Insurer's CEO Makes a Billion - WSJ.com
Wall Street Journal 04/18/2006
As sales growth slows in developed countries, pricing drops, and drug development is weak, the search for new avenues for growth.
Grouped Articles
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Glaxo to Weigh Results Of New Diet Pill
Wall Street Journal 10/24/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
BusinessWeek 12/05/2007
Osteoporosis Drug Is Amgen's Hope For a Strong Future
Wall Street Journal 12/14/2007
Glaxo Becomes Master of Reinventing Drugs
Wall Street Journal 04/17/2008
Western pharmaceutical companies are putting more emphasis on building sales in growing developing countries.
Grouped Articles
China Sentences Former Drug Regulator to Death
New York Times 05/29/2007
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Outlook Is Cut for U.S. Drug Sales
Wall Street Journal 10/29/2008
Drug Firms Target Newly Rich Abroad
Wall Street Journal 11/05/2008
As the R&D efforts of pharmaceutical companies become less productive new ways are being explored to develop new drugs for disease.
Grouped Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Research Chief Stirs Up Merck By Seeking Aid From Outsiders
Wall Street Journal 06/07/2006
Firms Study Drugs to Help Avert Diabetes - WSJ.com
Wall Street Journal 10/13/2006
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
BusinessWeek 12/05/2007
Sanofi Overhauls R&D To Help Costs, Pipeline
Wall Street Journal 07/01/2009
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1